Navigation Links
NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
Date:11/16/2009

is now poised to bring its lead product to patients and physicians. In addition, we continue to apply our knowledge and expertise in the development of other novel treatments for pain.

Our lead product, Qutenza(TM) (capsaicin) 8% patch, is a dermal delivery system containing a prescription strength of capsaicin that is currently approved in the United States and the European Union. Qutenza is expected to be launched by NeurogesX in the United States in the first half of 2010. In Europe, Qutenza will be marketed by Astellas Pharma Europe Ltd., (Astellas), the European subsidiary of Tokyo-based Astellas Pharma Inc.

NeurogesX's second most advanced product candidate, NGX-1998, is a topically applied, liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions. NGX-1998 has completed three Phase 1 studies.

NeurogesX's early stage product pipeline includes pre-clinical compounds, which are prodrugs of acetaminophen and various opioids. The company has evaluated these compounds in vitro and in vivo.

Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include but are not limited to: statements about the safety and efficacy of Qutenza(TM); the timing of launch and commercialization of Qutenza; and NeurogesX' plans to commercialize Qutenza with its own sales force. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limite
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. NeurogesX Expands Commercial Operations Leadership Team
2. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
3. NeurogesX to Present at JMP Securities Healthcare Focus Conference
4. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
5. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
6. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
7. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
8. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
9. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
10. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
11. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: VRX and ... prospectus supplement to its effective shelf registration statement on Form ... regulatory authorities in each of the provinces of ... its common shares to raise gross proceeds of approximately $1.75 ... to the underwriters of the Offering an option, exercisable for ...
(Date:6/17/2013)... , June 17, 2013 The following is ... The Partnership at Drugfree.org :   Last ... that it was halting the sale of prescription drug paraphernalia ... we recognize that from time to time there may be ... our customer. As a result of this misinterpretation we are ...
(Date:6/17/2013)... TORONTO , June 17, 2013 /PRNewswire/ ... that it entered into a securities purchase agreement with ... have agreed to purchase in a private placement an ... non-voting Series E 9% Convertible Preferred Stock ("convertible preferred ... of 100% of the shares of its common stock ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4A Win for Families: Urban Outfitters Halts Prescription Drug Paraphernalia Product Sales 2Generex Announces $1,225,000 Capital Investment 2Generex Announces $1,225,000 Capital Investment 3Generex Announces $1,225,000 Capital Investment 4Generex Announces $1,225,000 Capital Investment 5
(Date:6/18/2013)... 2013 Healthcare Solutions , ... Procura Management, today announced the appointment of Richard ... In this position, Leonardo will direct Healthcare Solutions’ ... strategic growth initiatives. , Recognized in the property ... Leonardo brings more than 20 years of experience ...
(Date:6/18/2013)... 18, 2013 New York magazine named 145 ... its “Best Doctors” list, up from 129 last year and ... new issue also lists 52 additional doctors who serve at ... strategic growth trajectory. The “Best Doctors” issue, which this year ... 24 print issue and is available online at http://www.nymag.com/bestdoctors ...
(Date:6/18/2013)... at University Hospitals Case Medical Center enrolled their first ... trial evaluating a novel, less-invasive procedure to help clear ... Every year, more than 300,000 people in the United ... carotid artery. If left untreated, these blockages can slow ... a potentially disabling stroke, also known as a "brain ...
(Date:6/18/2013)... Medicare penalties on hospitals with higher-than-expected rates of ... hospitals are evaluating the most accurate methods for ... appearing in the June issue of the ... finds that the American College of Surgeons National ... more accurate data tracking than another popular database, ...
(Date:6/18/2013)... Atlanta, GA (PRWEB) June 18, 2013 ... founder of the Atlanta Vision Institute, is pleased to ... the next generation of Intralase LASIK equipment, the iFS™ ... the only LASIK practice in Atlanta to offer its ... Dr. Ashraf is giving his patients a complimentary upgrade ...
Breaking Medicine News(10 mins):Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 2Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 3Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 4Health News:Atlanta LASIK Surgeon Offers New LASIK Technology 2
... (Nasdaq: HSKA ) announces the following Webcast: , What: ... Year-End 2008 Earnings Conference Call on the ... (MST], Where: www.heska.com (click on the Q4 and Year-End 2008 ... on the front page of this website)., How: ...
... University and Baxter Healthcare Corporation will create a ... announced today. , Under the three-year renewable agreement, ... levels for each year may reach approximately $1 ... levels on a case-by-case basis. Aligned with Baxter,s ...
... French . -->, ,Researchers ... Health Centre (RI MUHC) and the McGill University and Gnome ... Belgian institutions, have discovered DNA variations in a gene that ... in the January issue of the journal Nature Genetics ...
... Jan. 8 /PRNewswire-USNewswire/ -- Advocates for ... and reproductive health, has released an analysis showing ... lag far behind those in France, Germany, and ... , The U.S. teen birth rate, for example, ...
... Health Information Community brings together public-private sector ... networkWASHINGTON, Jan. 8 The National eHealth ... launched today in Washington, D.C. The ... dedicated to the creation of a secure, ...
... could indicate an epidemic of skin cancer, researchers suggest ... of the deadly skin cancer melanoma are increasing among ... older men, researchers report. , Whether the increase in ... However, the rate is increasing among all Americans and ...
Cached Medicine News:Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:Baxter and Northwestern University partner to target new life sciences projects 2Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 2Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 3Health News:U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach 2Health News:U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach 3Health News:National eHealth Collaborative Launched 2Health News:National eHealth Collaborative Launched 3Health News:National eHealth Collaborative Launched 4Health News:National eHealth Collaborative Launched 5Health News:National eHealth Collaborative Launched 6Health News:Melanoma Rates on the Rise in U.S. 2Health News:Melanoma Rates on the Rise in U.S. 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: